# Sunil Thakur

> Sunil Thakur is a private equity investor at Quadria Capital backing Health Care and Hospital. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Quadria Capital](https://shizune.co/investors/profile/quadria-capital)
- Location: New Delhi, India
- Total investments: 6
- Last investment: May 2024
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/pub/sunil-thakur/2/313/848

Sunil Thakur is a private equity investor at Quadria Capital in New Delhi focused on Health Care and Hospital. Sunil Thakur is the Director at Quadria Capital

## Round sizes

| Stage | Round size |
| --- | --- |
| Private Equity | $30M–$73M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 67% |
| Hospital | 2 | 33% |
| Medical | 1 | 17% |
| mHealth | 1 | 17% |
| Distillery | 1 | 17% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 2 | 33% |
| Series A | 1 | 17% |
| Series C | 1 | 17% |
| Series F | 1 | 17% |
| Funding Round | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NephroPlus | NephroPlus operates a network of dialysis centers with the goal of providing quality dialysis at low pricing through the use of standardized protocols, constant training, and focused innovation. The company's network provides dialysis, kidney stone treatment, arteriovenous fistula procedures, and other treatments linked to renal and urologicaldisorders. | $12M | Series F | May 03, 2024 |  |
| Ginglani Distillers | Ginglani Distillers operates as a whisky startup. Ginglani Distillers is the maker of Black Bow whisky. | $1.5M | Series A | Mar 26, 2024 |  |
| MediBuddy | MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $18M |  | Aug 30, 2023 |  |
| Maxivision Super Speciality Eye Hospitals | Maxivision Super Speciality Eye Hospitals is eye care hospital | $73.2M | Private Equity | Jul 12, 2023 |  |
| MediBuddy | MediBuddy is a digital healthcare platform for an inpatient hospitalization, outpatient services, and corporate wellness benefits.MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefitsindustry, makes the process of discovering, accessing, utilizing, and monitoring health benefits seamless, real-time, and virtually paperless. The company was founded in 2000 and based in Bangalore, Karnataka, India. | $125M | Series C | Feb 22, 2022 |  |
| Health Care At Home India | Health Care At Home is the best home health care service provider in India. We have a team of qualified doctors and skilled experts.In the future, the home will be the hub of all health care with all the technology being used in the field today pointing in this direction. For patients also, this is an ideal situation where they can heal faster andbetter in known and comfortable surroundings in addition to the advantage of being cost effective. Health Care at Home India is backed by the Burman family (the promoters of Dabur), with their proud legacy of trust and excellence for over 125 years. Our endeavour is also backed by the clinical credibility of the founders of the Health Care at Home UK, where the company has a healthy market share of 80% and is considered a leader and pioneer in home healthcare. In India, we look to bring significant value to the healthcare industry and the home health service sector by drawing synergies and lending support to existing organizations. Above all we aim to bring quality health care, offering comfort and convenience to the patient right at their door step. | $29.8M | Private Equity | Apr 03, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Lightrock india (Aspada)](https://shizune.co/investors/profile/aspada) — VC Fund, 2 deals together
- [TEAMFund](https://shizune.co/investors/profile/teamfund) — VC Fund, 2 deals together
- [Alteria Capital](https://shizune.co/investors/profile/alteria-capital) — VC Fund, 1 deal together
- [Anthill Ventures](https://shizune.co/investors/profile/anthill-ventures) — VC Fund, 1 deal together
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 1 deal together
- [Finfirst Group](https://shizune.co/investors/profile/finfirst-group) — VC Fund, 1 deal together

## About Quadria Capital

VC Fund · Singapore, Singapore

Quadria Capital is a healthcare focused private equity fund that invests in the high growth healthcare sector of some of the world's fastest growing economies in South Asia and Southeast Asia. Quadria Capital aims to generate significant financial returns for its investors by leveraging the team's operational and transactional experiencein healthcare to invest in high quality and scalable healthcare organizations to address the critical and undersupplied healthcare needs in the region.

3 contacts available at Quadria Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Amit Varma | Co-founder & Managing Partner | https://shizune.co/investors/profile/amit-varma-1e74 |
| Sunil Thakur | Director | https://shizune.co/investors/profile/sunil-thakur |
| Abrar Mir | Founder & Managing Partner | https://shizune.co/investors/profile/abrar-mir |

## Similar investors

### Similar industry
- [Imaginary Ventures](https://shizune.co/investors/profile/imaginary-ventures) — VC Fund
- [Distill Ventures](https://shizune.co/investors/profile/distill-ventures) — VC Fund
- [InvestBev](https://shizune.co/investors/profile/investbev) — VC Fund

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Wine And Spirits Angel Investors in India](https://shizune.co/investors/wine-and-spirits-angel-investors-india)

## FAQ

### What does Sunil Thakur invest in?

Sunil Thakur invests primarily in Health Care, Hospital and Medical startups, most often at Private Equity and Series A stage. Most of the 6 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Sunil Thakur's check size?

Sunil Thakur typically joins rounds of $30M–$73M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sunil Thakur participates in.

### When did Sunil Thakur last invest?

The most recent investment recorded for Sunil Thakur closed in May 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co